Location History:
- Mazkeret Batya, IL (2016 - 2018)
- Givat Brener, IL (2019 - 2022)
Company Filing History:
Years Active: 2016-2022
Title: Innovations in Cancer Therapy by Arthur Machlenkin
Introduction
Arthur Machlenkin is a notable inventor based in Mazkeret Batya, Israel. He has made significant contributions to the field of immunotherapy, particularly in cancer treatment. With a total of four patents to his name, Machlenkin's work focuses on improving T cell modulation and developing methods for cancer therapy.
Latest Patents
Machlenkin's latest patents include innovative methods for cancer therapy using isolated NTB-A ectodomain polypeptides. These inventions are directed towards enhancing T cell modulation both ex vivo and in vivo. The compositions and methods he has developed aim to treat cancer and other pathologies effectively. Specifically, his inventions utilize soluble NTB-A polypeptides or their agonists to treat cancer patients and prevent cytopenia in susceptible individuals. Additionally, he has provided methods for the ex vivo preparation of improved cell compositions for cancer therapy.
Career Highlights
Arthur Machlenkin is associated with Hadasit Medical Research Services and Development Ltd., where he continues to advance his research in immunotherapy. His work has garnered attention for its potential to revolutionize cancer treatment and improve patient outcomes.
Collaborations
Machlenkin collaborates with esteemed colleagues such as Michal Lotem and Shoshana Frankenburg. Their combined expertise contributes to the innovative research and development of new therapeutic methods.
Conclusion
Arthur Machlenkin's contributions to cancer therapy through his patents and research are paving the way for advancements in immunotherapy. His dedication to improving treatment options for cancer patients is commendable and highlights the importance of innovation in the medical field.